- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT00007748
Exercise and Behavioral Therapy Trial (EBT).
CSP#470 - A Randomized, Multi-Center, Controlled Trial of Multi-Modal Therapy in Veterans With Gulf War Illnesses
Studie Overzicht
Toestand
Conditie
Interventie / Behandeling
Gedetailleerde beschrijving
Primary Hypothesis:
The primary hypothesis is that both aerobic exercise and cognitive behavioral therapy (CBT) will significantly improve physical function (as measured by the Physical Component Summary Scale of the SF-36V) in veterans with Gulf War Veterans' Illnesses (GWVI), and the combination of cognitive behavioral therapy and aerobic exercise will be more beneficial than either therapy alone.
Secondary Hypotheses:
- Both aerobic exercise and CBT will lead to improvements in the cardinal symptoms of GWVI: pain, fatigue and cognitive difficulties.
- Both aerobic exercise and CBT will lead to decreased levels of distress in persons with GWVI.
- Both aerobic exercise and CBT will lead to improvements in emotional functioning in persons with GWVI.
Primary Outcomes: Improvement on the Physical Component Summary Scale of the SF-36V of more than 7 units at one year relative to baseline.
Interventions: Twelve one-hour weekly sessions of Cognitive behavioral therapy, aerobic exercise, the combination of the two therapies (12 one-hour sessions of CBT and 12 one-hour sessions of aerobic exercise) and a control group that receives usual and customary care.
Study Abstract: This trial was a study of Gulf War era veterans who have unexplained chronic medical symptoms such as pain, fatigue, and/or cognitive difficulties. All Gulf War veterans who were deployed to the South West Asia theater of operations between August 1990 and August 1991 were eligible for the study if they had at least two of the following three symptoms that began after August of 1990, lasting for more than six months and occurring up to present: 1. fatigue that limits usual activities (work, recreation, or social), 2. musculoskeletal pain involving two or more regions of the body, and neuro-cognitive dysfunction (self-reported difficulties in memory, concentration, or attention). Veterans who met enrollment criteria were randomized to one of four treatment arms: 1. CBT plus aerobic exercise, 2. aerobic exercise alone, 3. CBT alone, and 4. usual and customary care. Treatment was given for three months in group format. The CBT and exercise groups met for one hour, once a week for 12 weeks for a total of 12 hourly sessions. The interventions were standardized and all investigators were trained in the use of these methods prior to start up of the trial. The target sample size was 1064 veterans with GWVI to be accrued from 20 Medical Centers (18 VA and 2 DOD). All veterans were followed for one year and outcomes measured at 3 months (immediately following the end of treatment), 6 months and 12 months after enrollment.
The study was kicked-off in April 1999 and enrollment ended on September 5, 2000, during which 1092 veterans were randomized. Patient follow-up concluded on September 30, 2001 and the final DSMB meeting was held on November 28, 2001. The major finding was that there were no significant differences in the proportion of veterans who reported an improvement in physical function at one year among the treatment groups (11.5% for usual care, 11.7% for exercise, 18.4% for CBT and 18.5% for CBT + exercise). However, statistically significant improvements in fatigue, cognitive symptoms, distress, and mental health functioning were observed with exercise alone and with exercise plus CBT compared to usual care. CBT alone had a statistically significant effect on cognitive symptoms and in mental health functioning. Except for affective pain, which improved with CBT alone or with exercise, neither treatment had a significant effect on the other three measures of pain. In summary, neither exercise nor CBT had a significant impact on physical function for veterans with GWVI but both treatments, especially exercise, resulted in improvement in fatigue, cognitive symptoms, distress and mental health functioning.
Results embargoed until publication.
Studietype
Inschrijving
Fase
- Fase 3
Contacten en locaties
Studie Locaties
-
-
-
San Juan, Puerto Rico, 00921-3201
- San Juan Vamc
-
-
-
-
Alabama
-
Birmingham, Alabama, Verenigde Staten, 35233
- Birmingham Vamc
-
Birmingham, Alabama, Verenigde Staten, 35233
- Birmingham Vamc Birmingham Vamc
-
-
California
-
San Diego, California, Verenigde Staten, 92106-6000
- Naval Health Research Center, San Diego
-
San Diego, California, Verenigde Staten, 92152
- Naval Health Research Center, San Diego
-
San Diego, California, Verenigde Staten, 92186-5122
- Naval Health Research Center, San Diego
-
San Francisco, California, Verenigde Staten, 94121
- San Francisco VAMC
-
-
Connecticut
-
West Haven, Connecticut, Verenigde Staten, 06516
- VA CT Healthcare System, West Haven
-
-
District of Columbia
-
Washington, District of Columbia, Verenigde Staten, 20007
- Georgetown University Medical Center
-
Washington, District of Columbia, Verenigde Staten, 20307-5001
- Walter Reed Army Medical Center
-
-
Maryland
-
Bethesda, Maryland, Verenigde Staten, 20814-4799
- Uniformed Services University
-
-
Massachusetts
-
Boston, Massachusetts, Verenigde Staten, 02118
- Boston Medical Center
-
Boston, Massachusetts, Verenigde Staten, 02130
- Boston Vamc
-
Boston, Massachusetts, Verenigde Staten, 02114
- Boston Vamc
-
-
Missouri
-
St. Louis, Missouri, Verenigde Staten, 63106
- John Cochran VAMC, Saint Louis
-
-
New Jersey
-
East Orange, New Jersey, Verenigde Staten, 07018
- VA New Jersey Health Care System, East Orange
-
-
New Mexico
-
Albuquerque, New Mexico, Verenigde Staten, 87108
- Vamc - Albuquerque
-
-
New York
-
Brooklyn, New York, Verenigde Staten, 11209
- New York Harbor VA Healthcare System, Brooklyn Campus
-
-
North Dakota
-
Fargo, North Dakota, Verenigde Staten, 58102
- Fargo Vamc
-
-
Ohio
-
Dayton, Ohio, Verenigde Staten, 45428
- Vamc - Dayton
-
-
Oregon
-
Portland, Oregon, Verenigde Staten, 97207
- Portland Vamc
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, Verenigde Staten, 19104
- Philadelphia Vamc
-
-
Texas
-
Houston, Texas, Verenigde Staten, 77030
- Houston VAMC
-
San Antonio, Texas, Verenigde Staten, 78284
- Audie L. Murphy Memorial Veterans Hospital, San Antonio
-
-
Vermont
-
Burlington, Vermont, Verenigde Staten
- White River Junction VAMC
-
White River Jct., Vermont, Verenigde Staten, 05009
- White River Junction VAMC
-
-
Virginia
-
Richmond, Virginia, Verenigde Staten, 23249
- Richmond VAMC
-
-
Washington
-
Seattle, Washington, Verenigde Staten, 98108-1597
- VA Puget Sound Healthcare System, Seattle Division
-
Seattle, Washington, Verenigde Staten, 98108
- VA Puget Sound Healthcare System, Seattle Division
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Beschrijving
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Behandeling
- Toewijzing: Gerandomiseerd
- Interventioneel model: Faculteitstoewijzing
- Masker: Geen (open label)
Medewerkers en onderzoekers
Medewerkers
Studie record data
Bestudeer belangrijke data
Studie start
Studie voltooiing
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Schatting)
Updates van studierecords
Laatste update geplaatst (Schatting)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- 470
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .